A 23 yr old female nausea and vomiting after eating every meal she already tried ondansetran 4mg tablet tds and pantoprazole with domperidone
Reading File
Finding Sources
Finding Sources
Searching PubMed
nausea vomiting refractory treatment antiemetic
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
I now have sufficient information to provide a thorough clinical response. Let me compile it.
Clinical Assessment: 23-year-old Female with Postprandial Nausea & Vomiting - Treatment Failure
This patient has nausea and vomiting after every meal that has not responded to:
- Ondansetron 4 mg TDS (5-HT₃ antagonist)
- Pantoprazole (PPI)
- Domperidone (peripheral dopamine antagonist / prokinetic)
This treatment failure is a signal to re-evaluate the underlying diagnosis before escalating therapy.
Step 1 - Revisit the Differential Diagnosis
Postprandial nausea and vomiting in a young woman with no response to standard antiemetics should prompt workup for:
| Category | Consider |
|---|---|
| Gastroparesis | Idiopathic (young women), diabetic, post-viral |
| Functional GI | Chronic nausea-vomiting syndrome (CNVS), functional dyspepsia |
| Structural | Peptic ulcer, partial gastric outlet obstruction, superior mesenteric artery (SMA) syndrome |
| Cyclic vomiting syndrome (CVS) | Episodic but may appear continuous |
| Pregnancy | Always rule out in a 23-year-old female |
| Metabolic/endocrine | Hypothyroidism, Addison's disease, hypercalcaemia |
| CNS | Raised ICP (especially if morning vomiting, headache) |
| Psychogenic / eating disorder | Rumination syndrome, anxiety-driven |
| Medication side effects | Any current medications contributing? |
Key question: Has she had any workup? (UPT, gastric emptying study, upper endoscopy, thyroid/metabolic panel)
Step 2 - Why Current Treatment May Be Failing
- Ondansetron 4 mg TDS is useful mainly for chemotherapy-, radiation-, and postoperative nausea. It has limited efficacy in gastroparesis or functional nausea. (Harrison's 22e, Table 48-2)
- Domperidone is a prokinetic, effective in gastroparesis, but may be insufficient if the cause is not motility-based
- Pantoprazole addresses acid but does nothing for motility or functional nausea
The combination suggests a clinician is targeting GERD + motility, but if the underlying cause is functional (CNVS/CVS), structural, or metabolic, none of these will work.
Step 3 - Recommended Next Steps
Investigations First
- Urine pregnancy test (mandatory in any 23-year-old female with N&V)
- CBC, RFT, LFT, blood glucose, HbA1c, serum calcium, TSH
- Upper GI endoscopy - to rule out peptic ulcer, gastritis, outlet obstruction
- Gastric emptying scintigraphy (4-hour solid meal) - gold standard for gastroparesis
- Ultrasound abdomen - to rule out biliary/pancreatic pathology
Step 4 - Escalated Pharmacological Options
Based on Harrison's 22e and Yamada's Gastroenterology 7e:
If Gastroparesis confirmed:
| Drug | Dose | Notes |
|---|---|---|
| Metoclopramide | 10 mg TDS before meals | First-line prokinetic; 5-HT₄ agonist + D₂ antagonist; monitor for extrapyramidal effects with prolonged use |
| Erythromycin (low-dose) | 125-250 mg TDS before meals | Motilin agonist, short-term use only (tachyphylaxis) |
| Prucalopride | 2 mg OD | 5-HT₄ agonist; for idiopathic gastroparesis |
| Ondansetron 8 mg (higher dose) + promethazine | - | Combination antiemetic for symptom control |
| Tricyclics (amitriptyline) | 10-25 mg at night | Useful in gastroparesis + functional overlap |
If Chronic Nausea-Vomiting Syndrome (CNVS) / Functional (Rome IV criteria):
- Mirtazapine 7.5-15 mg at night - strong evidence for chronic nausea/vomiting syndrome and gastroparesis overlap (Harrison's 22e)
- Amitriptyline 10-25 mg at night - neuromodulator, first-line for functional nausea
- Olanzapine 2.5-5 mg - for refractory chronic nausea
- Gabapentin - useful in functional dyspepsia/gastroparesis overlap
If Cyclic Vomiting Syndrome suspected:
- Amitriptyline or topiramate (prophylaxis)
- Sumatriptan (abortive)
- Lorazepam (abortive during acute episodes)
Add-on symptom control options:
- Prochlorperazine 5-10 mg TDS (D₂ antagonist - different mechanism from ondansetron; effective for toxin/metabolic-driven emesis)
- Promethazine 12.5-25 mg - antihistamine + anticholinergic
- Haloperidol 0.5-1 mg - very effective when prochlorperazine or promethazine have failed (Textbook of Family Medicine 9e)
Step 5 - Non-Pharmacological Measures
- Small, frequent meals (5-6 small meals per day rather than 3 large)
- Low-fat, low-fibre diet (reduces gastric emptying delay)
- Avoid lying down for 2 hours post-meal
- Adequate hydration between (not during) meals
- Identify and stop any contributing medications
- Screen for anxiety/depression - bidirectional gut-brain axis plays a major role in young women with functional GI disorders
Summary Approach
Do not escalate antiemetics blindly. The priority is to establish a diagnosis via gastric emptying study + endoscopy. The most likely diagnoses are idiopathic gastroparesis or chronic nausea-vomiting syndrome (functional), both common in young women.
If investigations are unavailable immediately, a trial of metoclopramide 10 mg TDS before meals (replacing domperidone) combined with low-dose amitriptyline 10 mg at night is a reasonable empirical step while awaiting workup.
Sources: Harrison's Principles of Internal Medicine 22e, Yamada's Textbook of Gastroenterology 7e, Textbook of Family Medicine 9e
This is a shared conversation. Sign in to Orris to start your own chat.